Conference
Risankizumab in severe asthma: A Phase IIa, placebo-controlled study
Authors
Brightling CE; Nair P; Louis R; Singh D
Publisher
European Respiratory Society (ERS)
Publication Date
September 7, 2020
DOI
10.1183/13993003.congress-2020.3699
Name of conference
Airway pharmacology and treatment